chr15-40929848-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_019074.4(DLL4):c.68G>A(p.Arg23His) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,610,786 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_019074.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLL4 | ENST00000249749.7 | c.68G>A | p.Arg23His | missense_variant, splice_region_variant | 2/11 | 1 | NM_019074.4 | ENSP00000249749.5 | ||
DLL4 | ENST00000557876.1 | n.397G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000133 AC: 32AN: 240234Hom.: 1 AF XY: 0.000107 AC XY: 14AN XY: 131424
GnomAD4 exome AF: 0.0000596 AC: 87AN: 1458586Hom.: 1 Cov.: 32 AF XY: 0.0000496 AC XY: 36AN XY: 725584
GnomAD4 genome AF: 0.000355 AC: 54AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.000551 AC XY: 41AN XY: 74358
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at